Report

Cancer-Related Genetic Testing and Counseling. Workshop Proceedings

Released:: August 20, 2007
Type:: Workshop Summary
Topic(s):: Biomedical and Health Research, Children and Families, Diseases, Health Care Workforce, Quality and Patient Safety
Activity:: National Cancer Policy Forum
Board(s):: Board on Health Care Services

Note: Workshop Summaries contain the opinion of the presenters, but do NOT reflect the conclusions of the IOM. Learn more about the differences between Workshop Summaries and Consensus Reports.

The Institute of Medicine’s National Cancer Policy Forum held a workshop and released the proceedings entitled Cancer-Related Genetic Testing and Counseling. The workshop focused on the fact that genetic testing and counseling are becoming more complex and important for informing patients and families of the risks and benefits of certain courses of action, but at the same time organized expert programs are in short supply. The workshop covered the scientific and clinical aspects of genetic testing and counseling as well as workforce and reimbursement issues, among others.

The workshop proceedings capture the discussions and presentations by the speakers and participants.

Related Reports

Crisis Standards of Care: Summary of a Workshop Series Released: November 17, 2009
Systems for Research and Evaluation for Translating Genome-Based... Released: November 11, 2009
Integrative Medicine and the Health of the Public: A Summary of the... Released: November 4, 2009

Assessing and Improving Value in Cancer Care. Workshop Summary Released: November 4, 2009
A Review of the NIOSH Roadmap for Research on Asbestos Fibers and Other... Released: October 29, 2009
Community Perspectives on Obesity Prevention in Children. Workshop Summary Released: October 21, 2009

Childhood Obesity Prevention in Texas. Workshop Summary Released: October 21, 2009
School Meals: Building Blocks for Healthy Children Released: October 20, 2009
Global Issues in Water, Sanitation, and Health. Workshop Summary Released: September 25, 2009

back

Other Reports by this Activity

Displaying: 3 of 5 Reports

Assessing and Improving Value in Cancer Care. Workshop Summary Like other areas of health care, oncology is under pressure to control expenses while improving patient outcomes and the quality of care. Unlike many other areas of health care, however, oncology faces unique challenges that can make it especially difficult to control costs. On February 9-10, 2009, the National Cancer Policy Forum held a workshop to explore these issues from multiple perspectives, including those of patients and patient advocates, providers, insurers, health care researchers, federal agencies, and industry. Assessing and Improving the Value in Cancer Care summarizes workshop discussions and presentations.
Released: November 4, 2009
Ensuring Quality Cancer Care through the Oncology Workforce: Sustaining Care in the 21st Century. Workshop Summary The American Society of Clinical Oncology (ASCO) predicts that by 2020, there will be an 81 percent increase in people living with or surviving cancer but only a 14 percent increase in the number of practicing oncologists. As a result, there may be too few oncologists to meet the population’s need for cancer care. To help address the challenges in overcoming this potential crisis of cancer care, the National Cancer Policy Forum of the Institute of Medicine (IOM) convened the workshop “Ensuring Quality Cancer Care through the Oncology Workforce: Sustaining Care in the 21st Century” in Washington, DC on October 20 and 21, 2008.
Released: April 24, 2009
Multi-Center Phase III Clinical Trials and NCI Cooperative Groups. Workshop Summary The NCI-sponsored cooperative groups have made important contributions to improving treatment for many types of cancer, including breast, ovarian, colorectal, and childhood cancers. Cooperative group research has been instrumental in establishing innovative treatments that improve outcomes and quality of life. Despite these successes, the Cooperative Group Program has faced a number of challenges that threaten its effectiveness. To address this problem, the National Cancer Policy Forum (NCPF) convened a workshop titled “Multi-Center Phase III Clinical Trials and NCI Cooperative Groups” in Washington, DC, on July 1-2, 2008. The purpose of the workshop was to outline the challenges that the public clinical cancer research enterprise faces, and to identify possible solutions to these challenges.
Released: January 23, 2009